한빛사논문 | BRIC

한세원 님의 논문 목록

서울대학교병원

- 한세원(서울대학교병원)
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial
- Nat. Med., Dec 05 2023, | https://doi.org/10.1038/s41591-023-02696-8
- 2023-12
- 의약학
- 한빛사논문
Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer
- British Journal of Cancer, Published online06 January 2009, 100, 298 - 304 | doi:10.1038/sj.bjc.6604861
- 2009-01
- 상위피인용논문
RNA editing in RHOQ promotes invasion potential in colorectal cancer
- J. Exp. Med., Published March 24, 2014 | doi: 10.1084/jem.20132209
- 2014-03
- 의약학
- 한빛사논문
Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa®, ZD1839) in chemotherapy-resistant non-small cell lung cancer
- Int. J. Cancer, 2005, vol. 113, no1, pp. 109-115
- 2005-01
- 상위피인용논문
Optimization of Patient Selection for Gefitinib in Non-Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation
- Clin. Cancer Res., April 2006 12; 2538 | doi: 10.1158/1078-0432.CCR-05-2845
- 2006-04
- 의약학
- 상위피인용논문
Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non-Small-Cell Lung Cancer Patients Treated With Gefitinib
- J. Clin. Oncol., 10.1200/JCO.2005.01.388
- 2005-03
- 한빛사논문, 상위피인용논문

저자논문